Kobayashi Yasuyuki, Sano Shunji, Narumiya Yuto, Kimura Ayari, Suzuki Etsuji, Kasahara Shingo, Kotani Yasuhiro
Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Hospital, 2-5-1 Shikatacho, Kitaku, Okayama, Japan.
Department of Pediatric Cardiac Surgery, Showa University Hospital Toyosu, Tokyo, Japan.
Pediatr Cardiol. 2025 Jan 30. doi: 10.1007/s00246-025-03790-z.
We reviewed the outcomes of truncus arteriosus repair (primary vs. staged repair incorporating bilateral pulmonary artery banding), focusing on survival, reintervention, and functional data. We analyzed 39 patients who underwent a first intervention for truncus arteriosus (staged, n = 19; primary, n = 20) between 1992 and 2022. The median follow-up period was 8.0 (2.2-13.2) years. Survival, freedom from reoperation, and freedom from catheter intervention were estimated using the Kaplan-Meier method. High-risk patients were defined as those with a weight ≤ 2.5 kg, ≥ moderate truncal valve regurgitation, interrupted aortic arch, or preoperative shock. In the staged group, patients with a median weight of 2.6 kg had a median intensive care unit stay of 5 days and no hospital mortality after bilateral pulmonary artery banding. At repair, the staged group had a larger conduit for the right ventricular outflow tract (14 vs. 12 mm; P = .008). Catheter intervention on the branch pulmonary artery was required in 67% of patients in the staged group, but right ventricular end-diastolic pressure at follow-up was comparable between the groups (P = .541). Survival rates were higher among high-risk patients in the staged group (87.5% vs. 21.4% at 15 years; P = .004) but were comparable between groups for standard-risk patients (P = 1.000). Bilateral pulmonary artery banding was a safe, effective procedure. Reintervention for branch pulmonary artery was common but did not affect functional outcomes. Staged repair may play a pivotal role regarding survival in high-risk patients, and risk stratification is vital.
我们回顾了共同动脉干修复的结果(一期修复与采用双侧肺动脉环扎术的分期修复),重点关注生存率、再次干预情况和功能数据。我们分析了1992年至2022年间接受首次共同动脉干干预的39例患者(分期修复,n = 19;一期修复,n = 20)。中位随访期为8.0(2.2 - 13.2)年。采用Kaplan-Meier法估计生存率、免于再次手术率和免于导管介入率。高危患者定义为体重≤2.5 kg、存在中度及以上共同动脉干瓣膜反流、主动脉弓中断或术前休克的患者。在分期修复组中,中位体重为2.6 kg的患者在双侧肺动脉环扎术后在重症监护病房的中位停留时间为5天,且无医院死亡病例。在修复时,分期修复组右心室流出道的管道更大(14 vs. 12 mm;P = 0.008)。分期修复组67%的患者需要对分支肺动脉进行导管介入,但两组随访时的右心室舒张末期压力相当(P = 0.541)。分期修复组高危患者的生存率更高(15年时为87.5% vs. 21.4%;P = 0.004),但标准风险患者组之间的生存率相当(P = 1.000)。双侧肺动脉环扎术是一种安全、有效的手术。对分支肺动脉的再次干预很常见,但不影响功能结局。分期修复可能在高危患者的生存方面起关键作用,风险分层至关重要。